Epstein-Barr virus: an important vaccine target for cancer prevention. Academic Article uri icon

Overview

abstract

  • Participants at the February 2011 meeting at the U.S. National Institutes of Health on Epstein-Barr virus (EBV) vaccine research recommend that future clinical trials have two goals: prevention of infectious mononucleosis and EBV-associated cancers, facilitated by identification of disease-predictive surrogate markers.

publication date

  • November 2, 2011

Research

keywords

  • Herpesvirus 4, Human
  • Neoplasms
  • Viral Vaccines

Identity

PubMed Central ID

  • PMC3501269

Scopus Document Identifier

  • 80455164859

Digital Object Identifier (DOI)

  • 10.1126/scitranslmed.3002878

PubMed ID

  • 22049067

Additional Document Info

volume

  • 3

issue

  • 107